Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe - Lacour, J-P.; Ulrich, C.; Gilaberte, Y.; Von Felbert, V.; Basset-Seguin, N.; Dreno, B.; Girard, C.; Redondo, P.; Serra-Guillen, C.; Synnerstad, I.; Tarstedt, M.; Tsianakas, A.; et al. (Journal of the European Academy of Dermatology and Venereology, 2015)
Keywords: Aged; Aged, 80 and over; Aminolevulinic Acid - adverse effects; Aminolevulinic Acid - analogs & derivatives; Aminolevulinic Acid - therapeutic use; Europe; Facial Dermatoses - drug therapy; Female; Human health and pathology; Humans; Keratosis, Actinic - drug therapy; Life Sciences; Male; Middle Aged; Pain - etiology; Patient Satisfaction; Photochemotherapy - adverse effects; Photochemotherapy - methods; Photosensitizing Agents - adverse effects; Photosensitizing Agents - therapeutic use; Scalp Dermatoses - drug therapy; Severity of Illness Index; Single-Blind Method; Skin Cream; Sunlight - adverse effects; Treatment Outcome